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Abstract. A critical component to the success of software systems is the incor-
poration of the end user. Ensuring that the end user can use the system effec-
tively and efficiently is an important consideration. Failure to do this can lead to 
user error which in turn can have serious or even fatal consequences. To ad-
dress this issue in the medical domain, where the risk to patient and user safety 
is quite high, a number of standards and guidance documents promote the use 
of Human Factors and Usability Engineering techniques during the develop-
ment of devices. In this paper we introduce MeD UD (Medical Device Usabil-
ity Design) – A Process Reference Model (PRM) for evaluating usability engi-
neering in the medical device domain. Through a process assessment utilising 
the MeD UD PRM, medical device organisations can improve their usability 
design processes to achieve more usable products, reduce the risks associated 
with user errors and efficiently meet the medical device regulatory require-
ments. 
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1 Introduction 
The development of technology in recent years has allowed for medical devices to 
provide more effective and efficient patient care. These results can be attributed, in 
part, to the increasing role of software within medical devices. Through the use of 
software, complex configuration changes can be implemented easily. In 2006, it was 
noted that software was now incorporated into over half of the medical devices for 
sale on the U.S. market [1]. 
A side effect of the increased complexity of medical devices is the increased 
chance of human-error. Errors, slips and lapses can occur in every aspect of human 
activity. When these mistakes occur with medical devices the results can be fatal. In 
2007, Ms. Myra Jean Garman took her own life to escape the pain she suffered as a 
result of the misapplication of a medical device. Ms. Garman, who was suffering from 
breast cancer, was left in severe pain after she was given twice the recommended dose 
of radioactive seeds on five separate occasions. The state regulators attributed the 
over radiation to a mistake on behalf of a physicist who had entered an incorrect mag-
nification factor into the treatment planning computer. [2] Ms. Garman is unfortunate-
ly not an isolated incident. In New Jersey 36 cancer patients were over-radiated and a 
further 20 received substandard treatment due to human-error during the application 
of a medical device [2]. 
Errors like these can be reduced through the use of usability engineering. Usability 
engineering is the “application of knowledge about human behaviour, abilities, limi-
tations, and other characteristics related to the design of tools, devices, systems, 
tasks, jobs, and environments to achieve adequate usability” [3]. The incorporation of 
human aspects into the design process enables designers to develop interfaces in ac-
cordance with the users’ expectations and needs which can improve the overall user 
experience and reduce the likelihood of human error. 
Software Process Improvement (SPI) frameworks such as SPICE [4] or CMMI [5] 
allow organisations to improve their software development processes. These models 
divide the software development process into a number of discrete processes and 
outline the objectives to be achieved when undertaking these processes. Through an 
SPI assessment an organisation’s weaknesses and strengths can be identified and 
guidance can be provided as to how they can improve their existing processes. 
To assist organisations improve their usability design processes, this work outlines 
the MeD UD (Medical Device Usability Design) framework which has been devel-
oped specifically for the medical device domain. This framework incorporates the 
latest thinking from the IEC 62366:2007 [3] standard, and the US Food and Drug 
Administration (FDA)’s Applying human factors and usability engineering to opti-
mise medical device design [6] on the topic of usability and human factors engineer-
ing. 
The remainder of this paper is structured as follows: Section 2 provides the back-
ground to this work. Section 3 discusses software process improvement within the 
medical device domain. Section 4 describes the research methodology used during the 
development of MeD UD while Section 5 outlines the MeD UD framework. Section 6 
discusses how the MeD UD framework is different from existing usability assessment 
models. Section 7 then discusses the future of this work before the paper is concluded 
in Section 8.  
2 Background and Related Work 
2.1 The Role of Software in Medical Devices 
Software is omnipresent, affecting every aspect of our daily lives. It is incorporated in 
most household devices, including items as diverse as washing machines and DVD 
players, in motor vehicles, and even in wrist watches. It is no surprise therefore that 
medical devices are becoming more dependent on software. In 2006, Faris [1] found 
that software was incorporated in over 50% of medical devices for sale in the United 
States of America. 
The choice for using software in medical devices is motivated by the ease with 
which it can allow complex changes to be made, without the need for expensive 
hardware changes. However the use of software brings with it a number of risks. In 
the first half of 2010 the FDA recalled 23 medical devices which were classified as 
Class I, meaning that there is “reasonable probability that use of these products will 
cause serious adverse health consequences or death”. It was found that of these re-
calls 6 were likely to be caused by software defects [7]. 
Also in 2010 the FDA published a white paper [8] detailing an improvement initi-
ative which they undertook to improve the quality of infusion pumps. This initiative 
arose out of concerns due to the quality of infusion pumps being sold in the US. Be-
tween 2005 and 2009 the FDA received approximately 56,000 reports of adverse 
events associated with the use of infusion pumps, including numerous injuries and 
deaths. During this same period 87 infusion pumps were recalled, 14 of which were 
designated as Class I and 70 were designated as Class II, meaning that the use of the 
device may cause temporary or medically reversible adverse consequences or that the 
probability of serious adverse health consequences or death is remote.  
Many of these adverse events are related to deficiencies in device design and en-
gineering. Although the range of potential issues is quite large, in the report the FDA 
outline three of the most common types of problems reported, namely software de-
fects, user interface errors and mechanical or electrical failures.  
In 2007 the European Council amended the Medical Device Directive (MDD) [9], 
which governs the approval and marketing of medical devices in the European Union 
(EU). This amendment came into effect in March of 2010. As part of this amendment 
the EU recognized the importance of software and revised the directive to include the 
provision that software can now, in its own right, be classified as a medical device. As 
a result software can now be subjected to the same regulations and standards as other 
medical devices [10]. 
2.2 Medical Device Regulations, Standards and Guidance Documents 
In order to sell a medical device within the European Union (EU), the medical device 
organisation must demonstrate that they are compliant with the regulations set forth 
by the EU. Similarly, to sell medical devices within the US the organisation must 
demonstrate compliance with the FDA regulations [11]. In order to help organisations 
achieve compliance with these regulations the EU and FDA have published guidance 
documents that address specific aspects of the regulations and also recommend com-
pliance with harmonised and consensus international standards. Medical device or-
ganisations may chose not to follow these guidelines and standards and still receive 
approval to market their device; however they must provide strong justification for 
not doing so. 
One of the most fundamental requirements of a medical device organisation to 
achieve regulatory compliance is the implementation of a Quality Management Sys-
tem (QMS). A QMS ensures that the processes used during the development and pro-
duction of a medical device are defined and monitored to ensure high quality products 
are developed. The requirements of a quality management system have been outlined 
by the International Organisation for Standardization (ISO) in ISO 13485:2003 [12]. 
This standard is referred to by the European regulations and has recently been accept-
ed by the FDA as adequate fulfilment of the requirements of a QMS.  
As part of the QMS, organisations must perform risk management activities. To 
improve the quality of the medical devices, the organisation should identify all risks 
possible and take appropriate action to help mitigate these risks. ISO 14971:2007 [13] 
describes the requirements of a risk management process for medical device devel-
opment. This standard identifies 6 key stages; risk analysis, risk evaluation, risk con-
trol, evaluation of overall residual risk acceptability, risk management report, and 
production and post-production information. 
IEC 62304:2006 – Medical device software – Software life cycle processes [14] 
provides specific guidance on how to perform software development activities for 
software that is to be incorporated in a medical device. This is an EU harmonised 
standard and is recognised by the FDA as a consensus standard. It is therefore used to 
develop medical device software for both the European and US markets. 
2.3 Usability 
The ISO [15] define usability as “The extent to which a product can be used by speci-
fied users to achieve specified goals with effectiveness, efficiency and satisfaction in a 
specified context of use.” In this definition, the ISO identify three factors that should 
be considered when designing usable products; user, goals and context of use. A 
deep understanding of each of these factors is essential for the development of a usa-
ble application as they can all affect the way in which it is used. 
 User: - refers to the person that will interact with the application. By understanding 
the user of the system application designers can avoid a number of issues that can 
make a system difficult to use. For example, consider the development of a mobile 
application for the management of diabetes. Diabetic patients can suffer from reti-
nopathy which limits the patients’ vision thus making it difficult to see. During the 
design of a mobile application for diabetic patients knowledge of this may encour-
age developers to increase the size of fonts and objects displayed. 
 
 Goals: - refers to the intended outcome of the user. An understanding of the task to 
be completed can be critical to the success or failure of a product. During the de-
velopment of a new application the designer must understand what the user is try-
ing to accomplish as well as why they are doing it in such a way. In some cases it 
can be found that application designers are restricted in the improvements they can 
make by regulations. 
 
 Context of use: - refers to the location in which the application is to be used. This 
can include the physical and social elements of the environment in which the ap-
plication is to be used. The environment can limit the methods of input and output 
putting extra constraints on the developer. For example medical devices that are to 
be used in a noisy environment should contain alarms that can alert the user 
through the background noise, either through the use of a flashing light or a loud 
alarm. 
 
The ISO definition also outlines three measurable attributes that reflect the overall 
usability of the application:  
 Effectiveness: Accuracy and completeness with which users achieve specified 
goals; 
 Efficiency: Resources expended in relation to the accuracy and completeness with 
which users achieve goals; 
 Satisfaction: Freedom from discomfort, and positive attitudes towards the use of 
the product. 
A number of other models of usability have been proposed over the years. One of 
the most widely acknowledged was originally proposed by Nielsen [16]. In his model, 
Nielsen outlines five attributes of usability that should be considered: 
 Efficiency: Resources expended in relation to the accuracy and completeness with 
which users achieve goals; 
 Satisfaction: Freedom from discomfort, and positive attitudes towards the use of 
the product. 
 Learnability: The system should be easy to learn so that the user can rapidly start 
getting work done with the system; 
 Memorability: The system should be easy to remember so that the casual user is 
able to return to the system after some period of not having used it without having 
to learn everything all over again; 
 Errors: The system should have a low error rate, so that users make few errors 
during the use of the system and that if they do make errors they can easily recover 
from them. Further, catastrophic errors must not occur.  
Unlike the ISO, Nielsen does not consider effectiveness to be an attribute of usa-
bility, but instead an attribute of utility. In this model, Nielsen considers utility to be 
the ability of the system to allow the user to accomplish their task and is independent 
of usability. 
There are a number of techniques that can help application developers to develop 
usable products, such as user centred design. User centred design focuses on the 
needs, demands and requirements of the end user. Holzinger et al. [17] outlines one 
such process that has been proven on many projects. 
The protocol outlined in Fig. 1, adopted from [18], shows how user centred design 
can be performed, highlighting the role of the user throughout the development of the 
medical device. The process begins with the identification of end-users who are repre-
sented throughout the rest of the process. To aid in the development of a usable sys-
tem, after analysis the processes recommends the development of low-fidelity proto-
types that are tested with real users to determine which approaches work best. After 
this a high-fidelity prototype is developed which provides a rich user experience for 
the user to evaluate. The process then recommends development, once a suitable de-
sign has been found. This is then tested further to ensure it is usable before it is re-
leased. 
 
 
Fig.1. A Method for User Centred Design 
 
This approach makes extensive use of the Think Aloud protocol, which allows an-
alysts to understand how users approach a task by requiring them to describe what 
they are thinking while completing the task. This approach helps to reduce the costs 
as think aloud is a low cost method that can be applied throughout the development 
process from analysis to test. 
2.4 The Usability of Medical Devices 
Compliance with the standards outlined above can help to prevent software from fail-
ing through the elimination of software defects. Conformance with these regulations 
and standards do not provide protection against human error. More than 300 patients 
were over radiated by powerful CT scanners, which had obtained FDA approval, used 
to detect strokes in four hospitals in the US. In one hospital, which detected the errors 
after 18 months when patients started losing their hair, found that the overdose was 
displayed on-screen however the technicians administering the scans did not notice 
[2]. 
Similarly during an analysis of infusion pumps recalled by the FDA between 2005 
and 2009, user errors were identified as one of the most common cause of the recalls 
[8]. It was found that on some devices the screen failed to make clear the units of 
measurement (pounds vs. kilograms) when entering patient data for calculating the 
dosage, leading to incorrect dosages being applied. 
Although human error is an inevitable part of product usage, product designers 
have a responsibility to minimise the probability of human error occurring. To help 
developers achieve this goal usability practitioners have developed a series of heuris-
tics and guidelines that have evolved from common issues that have been found with 
other devices. For example, Jacob Neilsen has developed a set of 10 general purpose 
heuristics that should help prevent usability errors. These heuristics were based on an 
analysis of 249 usability problems observed in 11 projects [19]. A number of heuris-
tics such as these have emerged for a range of domains including the World Wide 
Web and mobile applications. 
Within the medical device domain ANSI/AAMI HE75:2009 [20] has been devel-
oped to provide a range of human factors design principles for medical devices across 
25 sections ranging “from general considerations for human interface design to spe-
cific medical considerations such as surgical tools, mobile devices and connectors” 
[21]. 
 In addition to the guidelines and design principles outlined above, the FDA and 
ISO recognise the importance of usability in a guidance document and international 
standard respectively. For medical devices sold within the US, the FDA have pro-
duced the Guidance document Applying human factors and usability engineering to 
optimise medical device design [6] which details a process for applying usability en-
gineering during medical device development.  
IEC have produced IEC 62366:2007 - Medical Devices – Application of usability 
engineering to medical devices [3] which is a FDA recognised consensus standard 
and is harmonized with the EU Medical Device Directive. IEC 62366 details the re-
quirements for applying usability engineering to the design and development of medi-
cal devices. The standard focuses predominantly on risk management and risk control 
but also outlines some of the key requirements for performing usability engineering 
activities, such as user and context identification and analysis. 
3 Software Process Improvement 
There are many reasons why organisations undertake software process improvement 
evaluations. General purpose software process improvement frameworks, such as 
CMMI [5] and ISO/IEC 15504-5:2012 [4], can be used to help organisations to identi-
fy areas in which their software development processes can be improved.  
In addition to this SPI models can be used to determine the state of a software de-
velopment organisations practices for the purpose of supplier selection. In the late 
1980s the US air force commissioned the development of a model to provide an ob-
jective evaluation of software subcontractors. This model, developed by the SEI at 
Carnegie Mellon University, became known as CMM and later CMMI. 
3.1 Software Process Improvement Within the Medical Device Domain 
The models described above have been developed for general purpose software pro-
cess assessment and as such do not provide sufficient coverage to achieve medical 
device regulatory compliance [22].  To address this issue a medical device specific 
SPI framework, titled Medi SPICE, has been developed.  
The objective of undertaking a Medi SPICE assessment is to determine the state of 
a medical device organisation’s software processes and practices. This is in relation to 
the regulatory requirements of the industry and best practice with the goal of  identi-
fying  areas for undertaking process improvement [22].  It can also be used as part of 
the  supplier selection process when an organisation wishes to outsource or offshore 
part or all of their medical device software development to a third party or remote 
division [23].  
Medi SPICE is based upon the latest version of ISO/IEC 15504-5:2012 [4] and 
ISO/IEC 12207:2008 [24]. It is being developed in line with the requirements of 
ISO/IEC 15504-2:2003 [25] and contains a  Process Reference Model (PRM) and 
Process Assessment Model (PAM). It also incorporates the requirements of the rele-
vant medical device regulations, standards, technical reports and guidance documents. 
The Medi SPICE PRM consists of 44 processes and 15 subprocesses which are 
fundamental to the development of regulatory compliant medical device software. 
Each process has a clearly defined purpose and outcomes that must be accomplished 
to achieve that purpose.  
Medi SPICE also contains a PAM which is related to the PRM and forms the basis 
for collecting evidence that may be used to provide a rating of process capability. This 
is achieved by the provision of a two-dimensional view of process capability. In one 
dimension, it describes a set of process specific practices that allow the achievement 
of the process outcomes and purpose defined in the PRM; this is termed the process 
dimension. In the second dimension, the PAM describes capabilities that relate to the 
process capability levels and process attributes, this is termed the capability dimen-
sion [26]. 
3.2 Capability Maturity Models in Healthcare 
Electronic health records pose serious risks to patient safety due to the volume of 
information they contain and the limited time available by medical practitioners to 
process these records. For this reason usability plays a major role in the presentation 
and organisation of medical health records and with healthcare organisations. 
In 2011 the Healthcare Information and Management Systems Society (HIMSS), 
through the HIMSS usability task force [27] introduced a healthcare usability maturity 
model to allow “health leaders and individuals to assess their levels of usability and 
then build to more advanced levels.” The proposed model contains five different as-
pects of usability within the healthcare organisation; focus on users, management, 
process & infrastructure, resources and education. 
The maturity model defines five levels at which an organisation can operate, 
summarised in the following table, taken from [27]: 
 
Phase Title Description 
1 Unrecognised 
Lack of awareness of usability. No practices, policies or 
resources 
2 Preliminary Sporadic inclusion of usability. Very limited resources 
3 Implemented Recognized value of usability. Small team doing usability 
4 Integrated 
All benchmarks of usability implemented including, a dedi-
cated user experience team 
5 Strategic 
Business benefits well understood, usability mandated, 
budget and people part of each year’s budget, results used 
strategically throughout the organisation 
Table 1. Healthcare usability Maturity Model Phases 
4 Research Methodology 
The aim of this work is to develop a software process improvement framework for 
medical device organisations’ usability engineering processes. To meet this aim, the 
authors have developed a PRM incorporating existing usability engineering standards 
and guidance documents and will subsequently develop an ISO/IEC 15504-2 compli-
ant PAM. The research methodology used is depicted in Fig. 2. 
 
 
 
 
 
It can be seen that the MeD UD PRM incorporates both existing usability stand-
ards and guidance documents and existing usability process improvement frame-
works. Both the ISO and the FDA have produced significant guidance documents 
relating to the incorporation of human factors and usability engineering into the de-
velopment of medical devices. An overview of these documents is provided in the 
following section.  
4.1 Usability Standards and Guidance Documents 
The IEC have produced the international standard IEC 62366:2007 – Medical Devices 
– Application of usability engineering to Medical Devices to help during the imple-
mentation of a usability engineering process. This standard specifies “a process for a 
manufacturer to analyse, specify, design, verify and validate usability, as it relates to 
safety of a medical device” [3]. 
The standard places a strong focus on the identification and elimination of risks 
associated with the use of the medical device. As part of the usability engineering 
process, the standard highlights the importance of the identification of Hazards and 
Hazardous situations, a critical component of the risk management process.   
In addition to this the standard in Section 5.7 Note 2, also recommends an iterative 
development cycle, specifying the need to perform usability validation throughout the 
design and development of the medical device.  
Existing usability process 
improvement frameworks 
MeD UD PRM 
ISO/IEC 15504-2 MeD UD PAM 
Existing usability standards 
and guidance documents 
Fig.2. Research Methodology 
As part of the usability engineering process, IEC 62366 specifies the need to per-
form usability verification, ensuring the user interface meets the requirements of the 
usability specification, and usability validation, ensuring that the primary operating 
functions can be accomplished through the user interface.  
The standard not only requires usability to be incorporated into the medical de-
vice, it specifies that usability engineering should also be applied to the development 
of the User Manual and other supporting documentation as well as to training users in 
the use of the medical device and all material necessary to support this training.  
While the standard does outline the requirements of the usability engineering pro-
cess, it does not specify specific methods for achieving these requirements. This ap-
proach allows the organisation to select the most appropriate methods for the devel-
opment of a particular medical device which meet the requirements of the standard. 
For medical device manufacturers wishing to distribute their products within the 
United States of America, the FDA have produced the guidance document “Applying 
human factors and usability engineering to optimise medical device design” [6]. 
This document also emphasises the need for the incorporation of usability and 
human factors engineering throughout the entire development lifecycle. While IEC 
62366 specifies that validation should be performed, the FDA guidance document 
provides guidance on how to perform validation, including the use of laboratory and 
clinical validation. 
In addition the FDA guidance document outlines some of the methods that can be 
used to identify hazards and hazardous situations including, contextual analysis, in-
terviews and focus groups, functional task analysis, Heuristic evaluation and Expert 
review.  
4.2 Usability Process Improvement Frameworks 
In addition to considering existing standards and guidance documents, during the 
course of this work a number of existing usability frameworks were considered. 
Trump [28] is an ISO/IEC 15504 compliant software process improvement method 
for human centred activities in the system lifecycle. The model is based on ISO 13407 
Human centred design processes for interactive systems [29].  
Trump has been developed to evaluate how well organisations are performing 
human centred design as part of system development and support projects. It can also 
be used to help organisations plan what human centred design activities to perform 
[28]. In addition to this the trump model can be used to help organisations evaluate 
their existing human-centred design activities. 
Within this model there are 7 processes relating to the incorporation of human-
centred activities into the software development process. The incorporated processes 
(descriptions taken directly from [28]) are: 
 Ensure  Human Centred Design (HCD) content in system strategy:  - Establish 
and maintain focus on stakeholder and user issues in each part of the organisation 
which deal with system markets, concepts, development and support; 
 Plan and manage the HCD Process: - Specify how the human centred activities 
fit into the whole system lifecycle process and the enterprise; 
 Specify stakeholders and Organisational requirements: - Establish the require-
ments of the organisation and other interested parties for the system. This process 
takes full accountability of the needs, competencies and working environment of 
each relevant stakeholder in the system; 
 Understand and Specify the context of use: - Identify, clarify and  record the 
characteristics of the stakeholders, their tasks and the organisational and physical 
environment in which the system will operate; 
 Produce design solutions:- Create potential design solutions by drawing on estab-
lished state of the art practice, the experience and knowledge of the participants 
and the results of the context of use analysis 
 Evaluate designs against requirements: - Collect feedback on the developing 
design. This feedback will be collected from end users and other representative 
sources 
 Introduce and operate the system: - Establish the human-centred aspects of the 
support and implementation of the system. 
An alternative to the Trump Assessment model is KESSU UD by Jokela [30]. 
Like Trump, KESSU UD is based on ISO 13407 but it also incorporates ISO/TR 
18529 [31]. The model has been developed as an objective model for facilitating dis-
cussions with development staff during and after usability maturity assessments. The 
model has also been used as a basis for project planning and communicating the es-
sence of usability to development managers and practitioners. 
The KESSU UD model consists of seven processes described below; 
 Identification of user groups: - During this processes the expected user groups 
are defined and categorised in a meaningful way. For example potential user 
groups on an infusion pump could be medical professionals, patients and home 
carers 
 Context of use analysis: - The goal of this process is to define the potential user 
groups tasks, and the environment in which these tasks will be performed. For ex-
ample a context of use for the aforementioned infusion pumps could be a noisy 
hospital ward in which a nurse could administer morphine to a patient. 
 User requirements determination: - This process defines the usability and User 
Interface (UI) design requirements. The requirements shall be used to drive deci-
sion making during the design of the final system. 
 User task redesign: - This process is used to design how users will carry out their 
task with the product under design. 
 Usability feedback: - This process facilitates the qualitative evaluation of the 
product.  
 Usability verification: - The usability verification process is used to measure the 
product under development against the usability and design requirements. 
 Interaction design: - During this process the elements of the system that the user 
will interact with (Buttons, Radio Boxes, Text Displays, etc.) are designed. This al-
so includes user documentation and training. 
5 Med UD  
The MeD UD framework, illustrated in Fig. 3 below, consists of 5 processes spanning 
the entire development process. The processes defined within the MeD UD frame-
work are performed during the requirements gathering, implementation and testing 
phases of the software development life cycle. The following provides a high level 
overview of the processes of the MeD UD Process Reference Model: 
 
Fig.3. The MeD UD Framework 
 
 UD1 – Usability requirements analysis: - The aim of this process is to define the 
usability requirements relating to the medical device. In defining these require-
ments the user, task, context and interaction are all considered. As part of the usa-
bility requirements all user groups are identified and analysed. During this analysis 
user profiles are created for each target user group and key characteristics, includ-
ing users’ level of training are considered. 
In addition to this all context(s) of use are identified and analysed. This analysis 
should include any environmental hazards that may be contained within the context 
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and their impact on the medical device and the interoperability of the medical de-
vice with other devices in the environment. 
The usability requirements analysis should also identify and analyse the expected 
user interaction with the medical device. A significant aspect to this process is the 
identification of the primary operating and frequently used functions. 
 
 UD2 - Risk management: - The second process is concerned with risk manage-
ment. As user error during the use of the medical device carries significant risk, 
risk management activities relating to the use of the medical device should be car-
ried out. This should be conducted in line with ISO 14971 (ISO, 2007), the risk 
management standard for the medical device domain, and focus on the risks asso-
ciated with usability. 
 
 UD3 - User interface design and implementation: - This process aims to mitigate 
against user risks through the development of the interface and supporting docu-
mentation. The interface should be developed in accordance with the usability 
specification. The supporting documentation should be developed in line with the 
user profiles so that it can be easily understood by the end user. The documentation 
should also include information relating to training in the use of the medical de-
vice. 
 
 UD4 - Usability validation: - The Usability validation process aims to ensure that 
all usability requirements have been met. Validation is performed on a medical de-
vice representing the finished product that has been successfully verified against 
the usability specification. 
Prior to the validation, a validation plan is prepared. The validation should be per-
formed in a realistic environment and should be sensitive enough to capture all use 
related problems whether or not the user is aware of such problems. The process 
covers both simulated use validation testing and clinical validation. 
─ Simulated use validation testing: - During simulated use testing the partici-
pants should be representative of actual end users and the environment should 
be sufficient to enable generalisation to the anticipated actual use. The valida-
tion should include both subjective and objective measures.  
─ Clinical validation: - The aim of clinical validation is to ensure adequate vali-
dation of the medical device within a clinical environment while ensuring the 
safety of participants and patients during the evaluation.  
 
 UD5 - Process management: - This process ensures the appropriate management 
of the usability engineering process through process management. The process 
should be managed and documented in line with the requirements of the quality 
management system. To ensure adequate documentation all results of the usability 
process should be maintained in the usability engineering file. 
6 Discussion 
The proposed MeD UD assessment model is different from existing process assess-
ment models for usability in a number of ways. Firstly, as the MeD UD assessment 
model has been developed based on guidelines from both the FDA and ISO it con-
tains a strong emphasis on risk management in line with ISO 14971.  
As part of the risk management process of MeD UD there is a requirement for or-
ganisations to identify the hazards relating to usability and the sequence or combina-
tion of events that can lead to a hazardous situation. This is not an explicit require-
ment in either the Trump or KESSU UD assessment models. 
In addition to this the MeD UD also requires the specific documentation of the us-
ability engineering process. This kind of documentation is mandated by the medical 
device regulations and as such is required in a usability assessment model for the 
medical device domain. In other domains such strict documentation is not required to 
market their products and is therefore not included within general usability assess-
ment models to the same extent as in MeD UD. 
The MeD UD assessment model has been developed to compliment Medi SPICE 
by focusing on the requirements for a usability engineering process. Should organisa-
tions wish to focus only on their usability processes they could undertake a MeD UD 
assessment rather than undertaking a full Medi SPICE assessment. 
7 Future work 
The next step of this work will be to validate the PRM. The PRM will be validated by 
experts from both academia and industry. As well as this it is intended to validate the 
model with experts within the software process improvement community. 
Once the PRM has been validated, the PAM will be developed. In order to do this, 
the transformation method developed by Barafort et al. [32] will be utilised. This 
transformation method identifies key requirements for the PAM, in this case the PRM 
presented above and through a goal oriented approach produces a ISO/IEC 15504 
compliant PAM. 
In order to further develop and test the MeD UD framework, a MeD UD assess-
ment will be performed within at least two medical device organisations. The goal of 
these assessments will be to identify the maturity of the organisation with regard to 
their software processes for usability and to assist them improve these processes. The-
se assessments will also be researched and based on the results finding reports pro-
duced and submitted for expert review. The MeD UD PRM and PAM will be updated 
and amended based on feedback from these expert reviews. 
8 Conclusions 
The misapplication of a medical device can have serious or even fatal consequences 
on both the user and the patient. For this reason, human factors and usability engi-
neering practices are used to minimise the risks associated with the use of a medical 
device by ensuring that users can operate the device in a safe, effective and efficient 
manner. 
A range of standards and guidance documents have emerged which can help de-
velopers implement these practices. These documents provide guidance on all aspects 
of development from the process to use to detailed guidelines on the most suitable 
components, and style of these components, to be used on a medical device.  
In this paper the MeD UD framework is introduced. The MeD UD framework is a 
process improvement framework for improving human factors and usability engineer-
ing processes within the medical device domain. The framework consists of five pro-
cesses across all aspects of the product development cycle. 
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